Geron
GERN
#6280
Rank
C$1.15 B
Marketcap
C$1.81
Share price
3.15%
Change (1 day)
-67.57%
Change (1 year)

Geron (GERN) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.16 Billion

According to Geron's latest financial reports the company's total debt is C$0.16 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Geron - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$0.17 B53.3%
2023-12-31C$0.11 B50.6%
2022-12-31C$75.65 M7.94%
2021-12-31C$70.09 M84.97%
2020-12-31C$37.89 M1036.02%
2019-12-31C$3.33 M
2018-12-31N/A
2005-12-31C$0.06 M-98.36%
2004-12-31C$3.89 M-51.47%
2003-12-31C$8.03 M-80.46%
2002-12-31C$41.1 M48.11%
2001-12-31C$27.74 M-44.48%
2000-12-31C$49.97 M89.36%
1999-12-31C$26.39 M90.74%
1998-12-31C$13.83 M321.07%
1997-12-31C$3.28 M-14.31%
1996-12-31C$3.83 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
C$0.76 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$34.45 B 20,357.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.54 B 223.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
C$57.01 M-66.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C$67.54 M-59.89%๐Ÿ‡บ๐Ÿ‡ธ USA